EBITDA margin společnosti Apellis Pharmaceuticals Inc
Jaká je hodnota metriky EBITDA margin společnosti Apellis Pharmaceuticals Inc?
Hodnota metriky EBITDA margin společnosti Apellis Pharmaceuticals Inc je -44,492.23%
Jaká je definice metriky EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Apellis Pharmaceuticals Inc
Čemu se věnuje společnost Apellis Pharmaceuticals Inc?
apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.
Firmy s metrikou ebitda margin podobnou společnosti Apellis Pharmaceuticals Inc
- Hodnota metriky EBITDA margin společnosti Walkabout Resources je -47,688.31%
- Hodnota metriky EBITDA margin společnosti Blue Star Helium je -47,121.89%
- Hodnota metriky EBITDA margin společnosti Mont Royal Resources je -45,543.49%
- Hodnota metriky EBITDA margin společnosti Checkpoint Therapeutics Inc je -45,501.28%
- Hodnota metriky EBITDA margin společnosti Metallica Minerals je -45,139.43%
- Hodnota metriky EBITDA margin společnosti Zeus Resources je -44,666.24%
- Hodnota metriky EBITDA margin společnosti Apellis Pharmaceuticals Inc je -44,492.23%
- Hodnota metriky EBITDA margin společnosti Nuveen NASDAQ 100 Dynamic Overwrite Fund je -44,294.34%
- Hodnota metriky EBITDA margin společnosti Leonovus je -44,280.00%
- Hodnota metriky EBITDA margin společnosti Lakes Oil NL je -43,029.19%
- Hodnota metriky EBITDA margin společnosti Aimmune Therapeutics Inc je -42,733.57%
- Hodnota metriky EBITDA margin společnosti Woomera Mining je -42,253.84%
- Hodnota metriky EBITDA margin společnosti Amarillo Biosciences je -40,922.42%